PGEN
NASDAQ
$5.07
Precigen Inc (PGEN)
Precigen, Inc. discovers and develops the next generation of cell and gene therapies in the United States. The company is headquartered in Germantown, Maryland.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $12.45 (+145.56%)
Market Cap
$1.82B
Free Cash Flow Yield
-6.42%
Beta (5Y)
1.66
Price Chart
Valuation
Market Cap$1.82B
Forward P/E250.00
P/S57.77
P/B90.21
Profitability
Total Revenue (TTM)$32M
Gross Profit (TTM)-$11M
EBITDA-$90M
Profit Margin-34.1%
Operating Margin-25.8%
EPS-$0.59
Financial Health
Debt-to-Equity462.2%
Free Cash Flow Yield-6.42%
Growth & Risk
EPS 5Y CAGR-3.91%
Revenue 5Y CAGR+3.45%
FCF 5Y CAGR+10.48%
Beta (5Y)1.66
Sharpe Ratio1.41